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Abstract 
Background: A number of engineered nanoparticles induce autophagy, the main catabolic pathway that regulates 
bulk degradation of cytoplasmic material by the lysosomes. Depending on the specific physico-chemical properties 
of the nanomaterial, however, nanoparticle-induced autophagy may have different effects on cell physiology, ranging 
from enhanced autophagic degradation to blockage of autophagic flux. To investigate the molecular mechanisms 
underlying the impact of nanoparticle charge on the nature of the autophagic response, we tested polystyrene nano-
particles (50 nm) with neutral, anionic, and cationic surface charges.
Results: We found all polystyrene nanoparticles investigated in this study to activate autophagy. We showed that 
internalization of polystyrene nanoparticles results in activation of the transcription factor EB, a master regulator of 
autophagy and lysosome biogenesis. Autophagic clearance, however, was observed to depend specifically on the 
charge of the nanoparticles. Particularly, we found that the autophagic response to polystyrene nanoparticles pre-
senting a neutral or anionic surface involves enhanced clearance of autophagic cargo. Cell exposure to polystyrene 
nanoparticles presenting a cationic surface, on the other hand, results in transcriptional upregulation of the pathway, 
but also causes lysosomal dysfunction, ultimately resulting in blockage of autophagic flux.
Conclusions: This study furthers our understanding of the molecular mechanisms that regulate the autophagic 
response to nanoparticles, thus contributing essential design criteria for engineering benign nanomaterials.
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Background
Engineered nanoparticles are widely explored for a vari-
ety of biomedical applications, including drug delivery 
[1–3], in vitro and in vivo diagnostics [4, 5], and produc-
tion of biocompatible materials [6, 7]. Because of their 
unique physical and chemical properties, nanoparti-
cles interact with biological components and systems, 
which also operate at the nanoscale. As a result, nano-
particles induce a variety of biological responses [8–16] 
including autophagy [17–21], the main catabolic path-
way that mediates degradation of aggregated proteins, 
damaged organelles, and pathogens by lysosomes [22]. 
Markers of autophagy have been detected upon cellular 
uptake of a variety of engineered nanoparticles, includ-
ing metal oxide nanoparticles [23, 24], quantum dots [19, 
25], fullerenes [21, 26], gold nanoparticles [18, 27], silver 
nanoparticles [28], and polymeric nanoparticles [29]. 
While autophagy is generally considered a pro-survival 
pathway [30–32], activation of autophagy has also been 
observed in association with cell death, suggesting that 
autophagy may play a role in the mechanism of nano-
particle-induced toxicity [33]. However, the molecular 
mechanisms that govern the autophagic response to nan-
oparticle internalization remain unclear.
Autophagic clearance is mediated by compartmen-
talization of cytoplasmic material into double-mem-
brane vesicles called autophagosomes [34]. Fusion of 
autophagosomes with lysosomes results in the formation 
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of autophagolysosomes where degradation occurs. As a 
result, autophagic clearance depends upon the coordi-
nated regulation of autophagosome and lysosome bio-
genesis and function. The transcription factor EB (TFEB) 
is a master regulator of the lysosome-autophagy system, 
controlling expression of the CLEAR (coordinated lyso-
somal expression and regulation) gene network [35]. 
Activation of TFEB increases the numbers of lysosomes 
[35] and autophagosomes, which are needed for degra-
dation of autophagic cargo [36]. Activation of TFEB has 
been observed upon internalization of synthetic nano-
particles [37] and autophagic clearance induced by ceria 
nanoparticles was found to specifically depend on TFEB 
activation [38].
Transcriptional activation of autophagy, however, is not 
always followed by an increase in autophagic clearance 
[39–43]. Nanoparticle uptake may result in impairment 
of downstream steps of the autophagy pathway, such as 
lysosomal function [27]. We hypothesize that nanoparti-
cle-induced impairment of lysosomal function may affect 
lysosome-autophagosome fusion, possibly leading to 
blockage of autophagic flux and cytotoxicity.
A number of endocytosed nanoparticles are found to 
accumulate in lysosomes [44–47]. Cationic nanoparticles 
have been reported to induce autophagy, but also to dis-
rupt lysosomes [12, 48, 49]. A “proton sponge” effect has 
been proposed as a potential mechanism for the observed 
lysosomal disruption and membrane permeabilization. 
Specifically, it was suggested that the high proton buff-
ering capacity of the amino groups on the nanoparticle 
surface interferes with acidification of lysosomes, impairs 
the proton pump activity, and ultimately induces lysoso-
mal membrane permeabilization [12].
We hypothesized that the surface charge of nanoparti-
cles plays an important role in determining the nature of 
the autophagic response that is induced upon nanopar-
ticle uptake. This hypothesis was investigated by testing 
the autophagic response activated upon cell exposure 
to non-functionalized polystyrene nanoparticles pre-
senting neutral surfaces (PS), carboxyl-functionalized 
nanoparticles presenting anionic surfaces (PS-COOH), 
and amino-functionalized nanoparticles presenting cati-
onic surfaces (PS-NH2). This study elucidates the cellu-
lar and molecular mechanisms that determine whether 
nanoparticle-mediated autophagy activation results in 
effective autophagic clearance or blockage of autophagic 
flux, thereby mapping the nanoparticle surface charge to 




Zeta potential measurements were conducted to verify 
the surface charge of polystyrene nanoparticles (50 nm) 
functionalized with neutral (PS), anionic (PS-COOH) 
and cationic (PS-NH2) groups in water, PBS, and cell cul-
ture medium (Table 1). All the polystyrene NPs present 
negatively charged zeta potentials in cell culture medium 
due to the formation of a negatively charged protein 
corona, as previously reported [12].
Nanoparticle concentrations are reported in units of 
µg/mL and were calculated assuming the density of the 
polystyrene nanoparticles in cell culture medium to 
approximately 1 g/cm3.
Polystyrene nanoparticles activate TFEB in HeLa/TFEB cells
To investigate the molecular mechanisms involved in the 
autophagic response to nanoparticles of different surface 
charge, we first analyzed the transcriptional regulatory 
network that controls autophagy activation by monitor-
ing TFEB intracellular localization in cells treated with 
PS, PS-COOH, and PS-NH2. TFEB localizes predomi-
nantly in the cytoplasm of resting cells and translocates 
into the nucleus upon activation [35]. We used HeLa cells 
stably transfected for the expression of TFEB-3xFLAG 
(HeLa/TFEB cells) because they provide an in vitro model 
system of TFEB activation [35]. HeLa/TFEB cells were 
treated with nanoparticles at final medium concentra-
tions ranging from 10 to 100 µg/mL and TFEB intracel-
lular localization was evaluated by confocal microscopy 
using Hoechst nuclear stain and an anti-FLAG antibody 
(Fig. 1a, b).
Table 1 Zeta potential and hydrodynamic diameter measurements of polystyrene nanoparticles in DI water, PBS, and cell 
culture medium
a A bimodal distribution of PS-NH2 in PBS indicates primary particles (54.0 ± 12.4 nm) and aggregates with an average hydrodynamic diameter of 340.1 ± 171.3 nm
Zeta potential (mV) Hydrodynamic diameter (nm)
DI water PBS Cell culture medium DI water PBS Cell culture medium
PS −8.0 ± 2.0 −16.7 ± 11.0 −13.9 ± 0.6 50.1 ± 1.0 49.4 ± 3.6 88.9 ± 1.8
PS-COOH −21.3 ± 2.2 −17.1 ± 7.7 −8.2 ± 2.6 60.3 ± 5.0 53.3 ± 14.5 53.5 ± 14.3
PS-NH2 +20.4 ± 1.3 +13.7 ± 3.3 −13.9 ± 0.3 74.8 ± 16.2 54.0 ± 12.4a 369.1 ± 29.3
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TFEB was found to localize predominantly in the cyto-
plasm of untreated HeLa/TFEB cells, as expected [35]. 
Specifically, the average fraction of TFEB that localizes in 
the nucleus of untreated cells was 29.1 ± 1.7 % (Fig. 1a). A 
significant increase in the fraction of TFEB that localizes in 
the nucleus was observed upon treatment with PS or PS-
COOH at medium concentrations of 50 µg/mL and higher. 
Specifically, the average fraction of TFEB that localizes in 
the nucleus was found to increase to over 40 % after 24 h of 
cell treatment with PS (50 µg/mL: 45.4 ± 3.3 %; 100 µg/mL: 
47.5 ± 1.0 %, Fig. 1a; p < 0.01) or PS-COOH (50 µg/mL: 
40.9 ± 1.4 %; 100 µg/mL: 49.5 ± 2.8 %, Fig. 1a; p < 0.01). 
Interestingly, the extent of TFEB activation was found not 
to reach a plateau upon cell treatment with concentrations 
of PS and PS-COOH higher than 100 µg/mL. A dramatic 
increase in TFEB nuclear localization was observed in 
cells treated with lower concentrations of PS-NH2 (10 and 
25 µg/mL) compared to PS and PS-COOH. After 24 h of 
treatment with PS-NH2, the average fraction of TFEB that 
localizes in the nucleus was found to increase to over 60 % 
(10 µg/mL: 62.4 ± 1.0 %; 25 µg/mL: 66.0 ± 3.7 %, Fig. 1a; 
p < 0.01). Cell treatment with higher medium concentra-
tions of PS-NH2 (50–100 µg/mL) resulted in considerable 
cytotoxicity and cell death, precluding accurate evaluation 






































































Fig. 1 Polystyrene nanoparticles promote TFEB activation in HeLa/TFEB cells. a Average fraction of TFEB that localizes in the nucleus of HeLa/TFEB 
cells untreated and treated with PS (50 and 100 µg/mL), PS-COOH (50 and 100 µg/mL), and PS-NH2 (10 and 25 µg/mL) for 24 h. Representative fields 
(~30) each containing approximately 50 cells were analyzed and data reported as mean ± SD (n = 3; p < 0.01). b Representative confocal micros-
copy images of TFEB subcellular localization in HeLa/TFEB cells treated with nanoparticles as described in a. UT, untreated. The scale bar is 10 μm.  
c Cellular uptake of polystyrene nanoparticles in HeLa/TFEB cells treated with nanoparticles as described in a. Data are reported as mean ± SD 
(n = 3; p < 0.05). d Confocal microscopy analyses of calcein (green) and EthD-1 binding (red) in HeLa/TFEB cells treated with PS (50 µg/mL),  
PS-COOH (50 µg/mL), and PS-NH2 (10 µg/mL) for 24 h. UT untreated. The scale bar is 40 μm
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These results indicate that cationic polystyrene nano-
particles induce TFEB activation in HeLa/TFEB cells to 
a higher extent than neutral and anionic nanoparticles 
and that the minimum concentration of cationic polysty-
rene nanoparticles needed to induce activation of TFEB 
is lower than that of neutral and anionic nanoparticles.
To investigate the correlation between activation of 
TFEB and uptake of polystyrene nanoparticles of differ-
ent surface charge, we measured the extent of nanoparti-
cle internalization in HeLa/TFEB cells under conditions 
observed to activate TFEB. Cellular uptake of fluores-
cently labeled polystyrene nanoparticles (PS, PS-COOH, 
and PS-NH2) was observed to follow a concentration-
dependent behavior under the conditions used in this 
study (Fig.  1c). Interestingly, the extent of TFEB activa-
tion was not found to vary dramatically above a minimum 
concentration that depends on the nanoparticle surface 
charge. These results suggest that TFEB activation may 
function as a switch-like response that is activated upon 
uptake of a critical nanoparticle concentration.
Polystyrene nanoparticle-induced toxicity was analyzed 
under conditions that result in TFEB activation in HeLa/
TFEB cells. As expected, we found that cell treatment 
with PS or PS-COOH (50  µg/mL; 24  h) does not cause 
cytotoxicity in HeLa/TFEB cells (Fig. 1d). Cell treatment 
with PS-NH2 (10 µg/mL; 24 h), however, results in con-
siderable cytotoxicity (Fig. 1d), possibly due to elevation 
of lysosomal pH and impairment of lysosomal integ-
rity [10, 12, 48]. These results suggest that the dramatic 
increase in TFEB activation observed in cells treated with 
low concentrations of PS-NH2 compared to PS or PS-
COOH may be due to lysosomal stress [50] caused by 
nanoparticle treatment under these conditions.
In summary, these studies indicate that cell treatment 
with neutral and anionic polystyrene nanoparticles (50 µg/
mL) does not induce cytotoxicity and results in activation 
of TFEB in HeLa/TFEB cells. However, treatment of the 
same cell line with cationic polystyrene nanoparticles at 
significantly lower concentrations (10–25 µg/mL) induces 
a higher extent of TFEB activation and cytotoxicity com-
pared to neutral and anionic nanoparticles. Higher con-
centrations of cationic nanoparticles (>25  µg/mL) were 
found to cause excessive cytotoxicity and cell death.
Polystyrene nanoparticles activate TFEB in PC12 cells
To further investigate how polystyrene nanoparticle sur-
face charge affects TFEB activation under conditions 
that do not induce significant cellular stress, we tested 
the impact of polystyrene nanoparticles with neutral, 
anionic, and cationic surface charge on TFEB intracel-
lular localization in PC12 cells. PC12 cells were selected 
for these studies because they are more resistant to 
many of the cytotoxic effects induced by the uptake of 
cationic nanoparticles including lysosomal permeabi-
lization, mitochondrial damage, and increased intra-
cellular and mitochondrial calcium levels [12]. PC12 
cells were treated with nanoparticles (10–100  µg/mL; 
24  h) and TFEB intracellular localization was evaluated 
and quantified as described above (Fig. 2a). TFEB local-
izes predominantly in the cytoplasm of untreated PC12 
cells, as observed in HeLa/TFEB cells. Specifically, the 
average fraction of TFEB that localizes in the nucleus of 
untreated cells was found to be 30.7 ± 0.7 % of the total 
TFEB (Fig. 2a). TFEB nuclear translocation was found to 
increase to over 50 % upon cell treatment with PS-NH2 
(50 µg/mL: 51.8 ± 5.3 %; 100 µg/mL: 51.7 ± 7.1 %), but 
not in cells treated with PS or PS-COOH at the same 
concentration (Fig.  2a; p  <  0.01). Representative images 
are reported in Fig. 1b.
Similar to what was observed in experiments con-
ducted using HeLa/TFEB cells (Fig.  1c), analyses of 
nanoparticle uptake revealed an increase in nanopar-
ticle uptake as a function of nanoparticle concentration 
in PC12 cells treated with PS and PS-COOH (Fig.  2c). 
However, the internalization of PS-NH2 was found not 
to increase with nanoparticle concentration, suggesting 
again that TFEB activation may function as a switch-like 
response that is activated upon uptake of a critical nano-
particle concentration.
Cytotoxicity analyses in PC12 treated with polysty-
rene nanoparticles revealed that, similar to HeLa/TFEB 
cells (Fig. 1), neither PS nor PS-COOH alter cell viability, 
while treatment with PS-NH2 results in considerable tox-
icity at the concentrations tested (Fig. 2d).
Collectively, these results indicate that cell exposure 
to polystyrene nanoparticles of different surface charge 
(neutral, anionic, cationic) results in activation of TFEB. 
These results also show that cationic polystyrene nano-
particles induce TFEB activation to a higher level than 
neutral or anionic polystyrene nanoparticles in all cell 
lines tested, both in terms of the extent of TFEB nuclear 
translocation and in terms of the minimal concentra-
tion of nanoparticle needed to observe TFEB activation. 
Moreover, the minimum medium concentration of cati-
onic nanoparticles that result in activation of TFEB in 
PC12 cells, which are more resistant to cationic nanopar-
ticle-induced cytotoxicity [12], was found to be higher 
than that observed in HeLa/TFEB cells, suggesting a cor-
relation between sensitivity to cationic nanoparticles and 
TFEB activation.
Clearance of autophagic cargo upon internalization 
of polystyrene nanoparticles depends on nanoparticle 
surface charge
To test whether polystyrene nanoparticle-induced TFEB 
activation parallels autophagic clearance, we monitored 
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the degradation of autophagic cargo. We used fibro-
blasts derived from a patient with late infantile neuronal 
ceroid lipofuscinosis (LINCL) which are characterized 
by accumulation of ceroid lipopigment [51]. Ceroid lipo-
pigment is a lipofuscin-like autofluorescent material 
[52] normally degraded through autophagy; LINCL cells 
thus provide a reliable in  vitro model system to quan-
tify autophagic clearance. Preliminary studies were con-
ducted to evaluate the minimum medium concentration 
of polystyrene nanoparticles required to activate TFEB 
in LINCL fibroblasts, as results obtained with HeLa/
TFEB and PC12 cells suggest that the extent of TFEB 
activation is cell type dependent. Cells were exposed to 
nanoparticles for 3 days, an incubation time necessary to 
monitor autophagic clearance [38]. Cell treatment with 
polystyrene nanoparticles (neutral, anionic and cationic) 
at 25 µg/mL causes an increase in the fraction of TFEB 
that localizes into the nucleus, compared to untreated 
cells (Fig.  3a, red). TFEB activation was observed upon 
treatment with low concentrations (25  µg/mL) of all 
three types of polystyrene nanoparticles possibly due 
to the prolonged time of incubation (3  days) of LINCL 
fibroblasts compared to HeLa/TFEB cells and PC12 cells 
(24 h).
Accumulation of ceroid lipopigment was moni-





































































Fig. 2 PS-NH2 promote TFEB activation in PC12 cells. a Average fraction of TFEB that localizes in the nucleus of PC12 cells treated with PS, PS-
COOH, and PS-NH2 (50 and 100 µg/mL) for 24 h. Representative fields (~30) containing approximately 50 cells were analyzed and data reported as 
mean ± SD (n = 3; p < 0.01). b Representative confocal microscopy images of TFEB subcellular localization in HeLa/TFEB cells treated with nanopar-
ticles as described in a. UT, untreated. The scale bar is 10 μm. c Cellular uptake of polystyrene nanoparticles in PC12 cells treated with nanoparticles 
as described in a. Data are reported as mean ± SD (n = 3; p < 0.05). d Confocal microscopy analyses of calcein (green) and EthD-1 binding (red) in 
HeLa/TFEB cells treated with PS (50 µg/mL), PS-COOH (50 µg/mL), and PS-NH2 (50 µg/mL) for 24 h. UT untreated. The scale bar is 40 μm
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nanoparticles under conditions found to activate TFEB. 
Confocal microscopy analyses showed that accumula-
tion of ceroid lipopigment was reduced in cells treated 
with PS or PS-COOH (Fig.  3a, green). Specifically, the 
fluorescence intensity of ceroid lipopigment decreased 
to approximately 60  % of the fluorescence intensity of 
untreated cells after treatment with PS or PS-COOH (PS: 
60.7 ± 15.0 %; PS-COOH: 60.5 ± 6.5 %, Fig. 3b; p < 0.01). 
Treatment with PS-NH2 under the same condition, how-
ever, was found not to affect the accumulation of ceroid 
lipopigment (Fig. 3a, green) despite the remarkable effect 
of PS-NH2 on TFEB activation. PS-NH2 treatment at 
higher concentrations resulted in considerable induction 
of cytotoxicity precluding accurate evaluation of ceroid 
lipopigment accumulation.
Cationic polystyrene nanoparticles impair lysosomal 
integrity and block autophagic flux
Autophagic clearance relies on the coordinated activation 
of lysosome and autophagosome biogenesis and function 
[53]. In addition to being transcriptionally upregulated, 
both branches of the lysosome-autophagy system need 
to be functionally active to promote autophagic clearance 
[39–43]. If lysosomal activity is impaired, transcriptional 
upregulation of autophagy genes and increased forma-
tion of autophagosomes are ultimately associated with 
decreased autophagic clearance [27].
To investigate the impact of the surface charge of poly-
styrene nanoparticles on lysosomal function, we assessed 
lysosomal integrity in fibroblasts treated with PS, PS-
COOH, and PS-NH2. Fibroblasts were treated with pol-
ystyrene nanoparticles (25  µg/mL) and collected every 
24  h for up to 72  h. Lysosomal integrity was evaluated 
using acridine orange (AO), a lysosomotropic probe that 
accumulates in acidic organelles and exhibits red fluores-
cence. The red fluorescence of AO dissipates upon lysoso-
mal membrane permeabilization when the dye is released 
into a more neutral environment. Therefore, a decrease 
in fluorescence intensity indicates abnormalities in lyso-
somal pH, or disruption of the lysosomal membrane. The 
fluorescence intensity of AO in cells treated with polysty-
rene nanoparticles was measured using flow cytometry, 
and lysosomal impairment was evaluated by calculating 
the percentage of cells that present low AO fluorescence 
as described in the Methods (AOlow cells; Fig.  4a). The 
total AO fluorescence relative to untreated cells was also 
quantified to evaluate lysosomal integrity in the entire 
cell population (Fig.  4b). Treatment with PS-NH2 but 
not with PS or PS-COOH was found to increase the per-
centage of cells presenting low AO fluorescence (Fig. 4a), 
indicating an increase in the number of cells with lysoso-
mal impairment upon PS-NH2 treatment. In addition, a 
significant decrease in the total AO fluorescence intensity 
in cells treated with PS-NH2 was observed, suggesting an 
average decrease in lysosomal integrity (Fig. 4b). Repre-
sentative histograms of cells treated with different types 
of polystyrene nanoparticle after 24 and 72 h are reported 
in Fig. 4c. Collectively, these results suggest that cationic 
polystyrene nanoparticles impair lysosomal integrity.
Because impairment of lysosomal integrity observed 
in cells treated with cationic nanoparticles may result 
from an increase in lysosomal pH induced upon accu-
mulation of cationic nanoparticles within lysosomes [10, 






























Fig. 3 Accumulation of ceroid lipopigment in LINCL fibroblasts treated with polystyrene nanoparticles. a Confocal microscopy analyses of TFEB 
(red) and ceroid lipopigment (green) in LINCL fibroblasts treated with PS, PS-COOH or PS-NH2 (25 µg/mL) for 3 days and evaluated by detecting 
green autofluorescence and binding of anti-TFEB antibody, respectively. UT untreated. The scale bar is 20 μm. b Quantification of ceroid lipopigment 
fluorescence intensity calculated as described in the “Methods”. Data are reported as mean ± SD (n = 15; *p < 0.01)
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in this study accumulate in the lysosomes under condi-
tions found to affect lysosomal integrity. Lysosomal accu-
mulation of polystyrene nanoparticles was evaluated by 
testing the colocalization of polystyrene nanoparticles 
and LAMP-2, a protein that resides on the membrane 
of lysosomes, using confocal microscopy [55]. All three 
types of polystyrene nanoparticles (PS, PS-COOH, and 
PS-NH2) were found to accumulate in lysosomes at each 
time point investigated (25 µg/mL; 24, 48, and 72 h) (see 
Additional file 1). Because lysosomal function and integ-
rity depends on the acidic pH of the lysosomal environ-
ment [56–58], these results suggest that impairment of 
lysosomal integrity observed upon uptake of cationic 
nanoparticles is possibly an effect of the nanoparticle sur-
face charge. These results would also explain why neutral 
and anionic nanoparticles were found to accumulate in 
the lysosome at each time point investigated, but were 
found not to affect lysosomal integrity.
Lysosomal membrane permeabilization may compro-
mise lysosome–autophagosome fusion. To test whether 
polystyrene nanoparticle treatment impairs lysosome–
autophagosome fusion, autophagolysosome formation 
was monitored under conditions that caused a change in 
lysosomal integrity. We evaluated the colocalization of 
LC3 and LAMP-2, which are proteins on the membranes 
of autophagosomes [59], and lysosomes [55], respec-
tively. Fibroblasts were treated with nanoparticles (25 µg/
mL) for up to 72  h. Colocalization was evaluated using 
confocal microscopy and quantified as described in the 





























































































































































































Fig. 4 Lysosomal integrity in fibroblasts treated with polystyrene nanoparticles. a Percentage of cells with low AO fluorescence (AOlow). AO fluo-
rescence intensity was measured by flow cytometry every 24 h for up to 72 h in fibroblasts treated with PS, PS-COOH or PS-NH2 (25 µg/mL). The 
results obtained from each replicate were acquired from the analysis of 10,000 cells. The percentage of cells with low AO fluorescence (AOlow) was 
calculated by normalizing the cell number with low AO fluorescence by the total cell number. Data are reported as mean ± SD (n = 3; p < 0.05). b 
Average AO fluorescence intensity measured by flow cytometry of cells treated with polystyrene nanoparticles as described in a. Data are reported 
as mean ± SD (n = 3; p < 0.05). c Representative histograms of cells treated with different types of polystyrene nanoparticle after 24 and 72 h. UT 
untreated
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of LC3 and LAMP-2 colocalization was observed in cells 
treated with PS or PS-COOH compared to untreated 
cells (untreated: 10.1  ±  1.8  % after 24  h, 10.3  ±  2.1  % 
after 48 h, 9.7 ± 2.2 % after 72 h. PS: 19.1 ± 3.4 % after 
24  h, 16.1  ±  1.7  % after 48  h, 17.7  ±  3.3  % after 72  h. 
PS-COOH: 18.4 ±  2.9  % after 24  h, 18.8 ±  3.8  % after 
48  h, 16.9  ±  1.8  % after 72  h) (Fig.  5a; p  <  0.01), indi-
cating that neutral and anionic polystyrene nanoparti-
cles promote fusion of autophagosomes and lysosomes 
and formation of autophagolysosomes. The extent of 
colocalization of LC3 and LAMP-2 in cells treated with 
PS-NH2 reached 24.3  ±  3.5  % after 24  h of incubation 
and 24.6 ± 4.4 % after 48 h, but decreased to 13.7 ± 1.7 % 
after 72  h (Fig.  5a; p  <  0.01), indicating that formation 
of autophagolysosomes is ultimately impaired by cati-
onic nanoparticle treatment. Representative images of 
untreated cells and cells treated with PS, PS-COOH and 
PS-NH2 are reported in Fig. 5b–e.
These results indicate that lysosomal accumulation of 
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Fig. 5 Colocalization of LC3 and LAMP-2 in fibroblasts treated with polystyrene nanoparticles. a Quantification of LC3-LAMP-2 colocalization in 
fibroblasts treated with polystyrene nanoparticles (50 nm; 25 µg/mL) calculated as described in the “Methods”. UT untreated. Data are reported as  
mean ± SD (n = 15; *p < 0.01). b–e Representative confocal microscopy images of LC3 (red) and LAMP-2 (blue) in b untreated fibroblasts (UT) and 
in fibroblasts treated with c PS (25 µg/mL), d PS-COOH (25 µg/mL), e PS-NH2 (25 µg/mL) after 24, 48, and 72 h evaluated by detecting binding of 
anti-LC3 antibody and binding of anti-LAMP-2 antibody, respectively. Colocalization of LC3 (red) and LAMP-2 (blue) is shown in merged images 
(purple). The scale bar is 20 μm
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charges cause induction of the autophagic response 
through activation of TFEB, which manifests as an 
increase in lysosome–autophagosome fusion and, 
ultimately, enhanced clearance of autophagic cargo. 
Lysosomal accumulation of nanoparticles presenting 
positive surface charge, however, causes activation of 
the autophagic response, but also lysosomal dysfunction. 
As a result, internalization of polystyrene nanoparticles 
presenting positive surface charge eventually manifests 
as blockage of autophagic flux and does not result in a 
change in clearance of autophagic cargo.
Discussion
In this study, we investigated the molecular mechanisms 
associated with the autophagic response to polysty-
rene nanoparticles as a function of nanoparticle surface 
charge. Cationic nanoparticles were found to induce 
activation of TFEB, a master regulator of lysosome bio-
genesis and autophagy, to a higher level than neutral 
or anionic nanoparticles, both in terms of the extent of 
TFEB nuclear localization and the minimal concentration 
of nanoparticle needed to observe an increase in TFEB 
activation.
Downstream steps of the autophagy pathway, namely 
lysosomal function, lysosome-autophagosome fusion, 
and clearance of autophagic cargo were also monitored to 
establish a correlation between transcriptional activation 
of autophagy and the nature of the autophagic response 
induced upon uptake of nanoparticles. Cell treatment 
with neutral and anionic polystyrene nanoparticles was 
found to upregulate the autophagy system, enhance 
autophagic activity, and, ultimately, increase clearance of 
autophagic substrates. Cell treatment with cationic poly-
styrene nanoparticles, on the other hand, was found to 
cause impairment of lysosomal integrity, reduced forma-
tion of autophagolysosomes and, ultimately, blockage of 
autophagic flux. As a result, activation of the autophagic 
response observed in cells treated with cationic nano-
particles does not parallel an increase in degradation of 
autophagic substrates.
Nanoparticle aggregation is commonly observed upon 
cellular internalization, typically due to the high ionic 
strength conditions of the cytosolic environment [8, 60]; 
whether nanoparticle aggregation plays a role in the acti-
vation of TFEB observed in response to cell treatment 
with polystyrene nanoparticles remains to be determined.
High levels of both autophagy and cell death are often 
observed under stress conditions induced by accumula-
tion of positively charged nanoparticles in lysosomes, 
suggesting that cell death under these conditions is 
mediated by autophagy. Generally speaking, a num-
ber of stressful stimuli that ultimately lead to cell death 
initially induce activation of autophagy as a pro-survival 
pathway. This observation has led to the assumption that 
autophagy contributes to cell death [30]. Cell death by 
autophagy, however, is expected to result in upregulation 
of the autophagy system including increase in autophagic 
flux [61, 62]. Interestingly, cationic nanoparticles induce 
activation of TFEB that is not paralleled by increase in 
degradation of autophagic cargo but rather by impair-
ment of lysosomal function, suggesting that cell death 
under these conditions is not caused by autophagy, but 
rather by impairment of autophagy.
This study provides a mechanistic understanding of 
the interaction of polystyrene nanoparticles of differ-
ent surface charges with the autophagic pathway and 
contributes to defining the design rules for engineering 
nanoparticles with desired effect on the autophagy sys-
tem and nanotherapeutics for the treatment of diseases 
characterized by inefficient autophagic activity and accu-
mulation of storage material.
Conclusions
These results demonstrate that cell exposure to neutral 
and anionic polystyrene nanoparticles results in TFEB 
activation, enhancement of autophagic activity, and, 
ultimately, increased degradation of autophagic cargo. 
Cationic polystyrene nanoparticles induce activation of 
TFEB, but also cause impairment of lysosomal integrity, 
reduced formation of autophagolysosomes, and, ulti-
mately, blockage of autophagic flux.
Methods
Reagents and cell cultures
Polystyrene nanoparticles were purchased from Mag-
sphere or Phosphorex (see Additional file 2). Bafilomycin 
was purchased from Cayman Chemical, Acridine Orange 
was from Invitrogen. Cell culture medium, PBS, and Try-
pLE Express were from Lonza.
Fibroblasts derived from Late Infantile Neuronal 
Ceroid Lipofuscinosis (LINCL) patients were from 
Coriell Cell Repositories (GM16486). HeLa cells stably 
transfected for the expression of TFEB-3xFLAG were a 
gift from Dr. Sardiello [35]. Cells were grown at 37 °C in 
5 % CO2 in Dulbecco’s Modified Eagle Medium supple-
mented with heat-inactivated fetal bovine serum (20  % 
FBS for LINCL fibroblasts, 10 % FBS for HeLa cells) and 
1 % glutamine Pen-Strep. Monolayers were passaged with 
TrypLE Express.
PC12 cells were from ATCC. Cells were grown at 37 °C 
in 5  % CO2 in Dulbecco’s Modified Eagle Medium sup-
plemented with 5 % heat-inactivated fetal bovine serum, 
10  % horse serum and 1  % glutamine Pen-Strep. Mon-
olayers were passaged with TrypLE Express.
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Characterization of nanoparticles
The surface charge and hydrodynamic diameter of poly-
styrene nanoparticles was analyzed using a Brookhaven 
Instruments ZetaPALS system and a Beckman Coulter 
DelsaMax Pro system.
Cellular uptake of polystyrene nanoparticles
Nanoparticle uptake was evaluated as previously 
reported [63]. Briefly, 104 cells were plated in each well 
of 96-well plates and incubated overnight. Cells were 
exposed to nanoparticles for 24  h, washed three times 
with PBS, and lysed with the complete lysis-M buffer 
containing the protease inhibitor cocktail (Roche). The 
fluorescence intensity of the cell lysate was quantified 
using a SpectraMax Gemini plate reader (Molecular 
Device) (excitation 488  nm, emission 530  nm). The flu-
orescence intensity of cell lysates was normalized to the 
absolute fluorescence of each corresponding nanoparti-
cle to calculate the intracellular concentration of polysty-
rene nanoparticles.
Immunofluorescence assays
TFEB intracellular localization was evaluated by confo-
cal microscopy using Hoechst nuclear stain (Enzo Life 
Sciences), and an anti-FLAG antibody (Sigma-Aldrich) 
or an anti-TFEB antibody (Abcam Inc). The percentage 
of TFEB nuclear localization was calculated by normal-
izing the fluorescence intensity of TFEB that localizes 
in the nucleus by the total fluorescence intensity of 
TFEB in each cell measured using MATLAB. Average 
values were calculated over 30 images each containing 
~50 cells and collected from at least three independent 
experiments.
The accumulation of ceroid lipopigment was quan-
tified as previously described [52]. Average values 
were calculated over 30 images each containing ~5–10 
cells and collected from at least three independent 
experiments.
The colocalization of LC3 (red) and LAMP-2 (blue) was 
evaluated by confocal microscopy using an anti-LC3 anti-
body (Novus Biologics) and an anti-LAMP-2 antibody 
(BioLegend). Colocalization was quantified by calculat-
ing the number of pixels with both red and blue signals 
above a predefined brightness threshold (grey scale >30, 
range 0–255) and with a red to blue ratio within a prede-
fined range (0.5–2). The percentage of colocalization was 
calculated by normalizing the number of pixels present-
ing LC3 and LAMP-2 colocalization to the total num-
ber of pixels in each cell over the entire image. Average 
values were calculated over 30 images each containing 
~5–10 cells and collected from at least three independent 
experiments.
Cell viability assays
Cell viability assays were performed using the LIVE/
DEAD® Viability/Cytotoxicity assay according to the 
manufacturer’s specifications (Life Technologies). Images 
were obtained using an Olympus IX81 confocal micro-
scope and co-localized using Fluoview software.
Lysosomal integrity assays
Lysosomal integrity was analyzed using acridine orange 
(AO) as previously described [12]. Cells were incubated 
with nanoparticles for 24 h and exposed to 1 μg/mL AO 
for 15  min at 37  °C. Samples (10,000 cells) were ana-
lyzed by flow cytometry (FACSCanto™ II) using a 488-
nm Argon laser and a 670-nm emission filter. The cell 
population presenting low AO fluorescence was defined 
by setting the gate boundary corresponding to 2  % of 
untreated cells presenting low AO fluorescence.
Statistical analyses
All data is presented as mean ± S.D., and statistical sig-
nificance was calculated using a two-tailed t test.
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